98%
921
2 minutes
20
Dicentric chromosome analysis (DCA) has limitations in its use for the evaluation of the radiation dose upon the development of medical radiation equipment due to its time/labour-consuming procedure and the requirement of highly trained experts. Therefore, we aimed to construct a dose-response curve using a semi-automatic cytokinesis-block micronucleus (CBMN) analysis method that can be easily analysed and utilised by anyone. CHO-K1 cells were exposed to gamma rays at various doses (0-4 Gy). For the CBMN assay, the bi-nucleated cells were selected and captured, and micronuclei (MN) scoring was automatically performed using the Metafer4 system. The MN scores were manually confirmed and corrected by analysts. Using the frequency distributions of MN according to the radiation dose, the dose-response calibration curve was generated using Dose Estimate v5.2 software. The equation of dose-response calibration curve is Y = 0.0299 (±0.0057) + 0.1502 (±0.0151) × D + 0.0111 (±0.0048) × D. The goodness-of-fit parameters were also calculated (chi-squared [ ] = 39.45, degrees of freedom = 5, = 0.0000). The semi-automated CBMN assay consist of two steps: the automated MN capture/scoring step and the manual confirmation/correction step. Using an established dose-response calibration curve and the procedure of the semi-automated CBMN assay, the dose-estimation of gamma-irradiated (0.5 or 2 Gy) CHO-K1 cells were performed by two analysts individually, and it was inter-compared to verify the accuracy, the results showed that the estimated doses were a good fit the applied doses of radiation. The CBMN assay using CHO-K1 cells can be easily used as a biodosimetry tool for dose assessment of medical radiation equipment due to the advantage of being simple, easy, and quick to measure the dose.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12144914 | PMC |
http://dx.doi.org/10.14293/genint.15.1.003 | DOI Listing |
IEEE Trans Med Imaging
September 2025
Photon-counting computed tomography (PCCT) based on photon-counting detectors (PCDs) represents a cutting-edge CT technology, offering higher spatial resolution, reduced radiation dose, and advanced material decomposition capabilities. Accurately modeling complex and nonlinear PCDs under limited calibration data becomes one of the challenges hindering the widespread accessibility of PCCT. This paper introduces a physics-ASIC architecture-driven deep learning detector model for PCDs.
View Article and Find Full Text PDFMed Phys
September 2025
Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Background: Estimating dose delivered to patients for a typical mammographic or radiologic examination requires accurate knowledge of several beam quantities. X-ray multimeters (XMMs) are compact, solid-state semiconductor dosimeters that have become common for conventional QA measurements due to their ease of use.
Purpose: In this investigation, the performance of two XMMs in low-energy x-ray calibration beams was assessed, and the stability of the manufacturer's calibration over time was evaluated.
Phys Med Biol
September 2025
Radiation Oncology, The University of Texas Southwestern Medical Center, 2280 Inwood Road, Dallas, Texas, 75235, UNITED STATES.
Objective: This study aims to investigate the responses of prototype diamond detectors under pulsed ultra-high dose rates (UHDR) pencil-beam-scanning (PBS) protons from a compact proton synchrocyclotron (IBA Proteus®ONE) for small-field UHDR dosimetry.
Approach: flashDiamond detectors (fD) were cross-calibrated with their relative proton responses characterized at conventional dose rates (CONV). Then, absolute UHDR dosimetry was performed and small-field response assessed.
NPJ Syst Biol Appl
September 2025
Pharmacometrics & Systems Pharmacology, Pfizer Research & Development, San Diego, CA, USA.
Elranatamab, an approved bispecific antibody (BsAb) for relapsed/refractory multiple myeloma, forms an immune synapse between the T-cell CD3 marker and B-cell maturation antigen (BCMA) on myeloma cells. Circulating soluble BCMA (sBCMA) is associated with disease burden and may reduce drug exposure, impacting efficacy. A quantitative systems pharmacology model that captures elranatamab's mechanism of action and disease dynamics was developed and calibrated to clinical datasets.
View Article and Find Full Text PDFBMC Geriatr
August 2025
Qingdao Traditional Chinese Medicine Hospital, Qingdao Hiser Hospital Affiliated of Qingdao University, Qingdao, 266000, China.
Objective: This study investigates the relationship between the Kidney Disease Index (KDI) and cognitive function, evaluating its potential as a predictive marker for cognitive impairment in older adults. We also compare the performance of KDI with traditional kidney function markers, including estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR), in predicting cognitive decline.
Methods: Data from the National Health and Nutrition Examination Survey (NHANES) involving participants aged 60 years or older were analyzed.